LyGenesis
Business Services · Pennsylvania, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1710 Murray Ave Ste 200, Pittsburgh, Pen...Phone Number
(412) 449-9983Website
www.lygenesis.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About LyGenesis
LyGenesis, Inc. is a clinical-stage cell therapy company that focuses on addressing life-threatening diseases such as Type 1 diabetes and end-stage liver and renal disease. Their innovative approach utilizes patients' lymph nodes as bioreactors to grow functioning ectopic organs, significantly improving the economics and logistics of organ transplantation. By employing an outpatient endoscopic ultrasound procedure, their therapies reduce medical risks and costs compared to traditional organ transplants. The company is advancing its pipeline through various phases of clinical trials for multiple organ therapies.Explore more
LyGenesis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LyGenesis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if LyGenesis has recently received funding, and reach out quickly before it becomes old news!
Check out if LyGenesis is spiking on competitors!
Product Launch: Get notified when LyGenesis launches new products
Congratulate Masked Content for being promoted to Masked Content at LyGenesis
Funding: Get notified immidiatlly once LyGenesis has new funding data
Website visits: Recent activity has been detected on your website
LyGenesis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on LyGenesis recently announced quarterly report
Click to see if LyGenesis had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to LyGenesis
Compare insights from companies similar to LyGenesis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$7.7M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
LyGenesis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LyGenesis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LyGenesis.
LyGenesis financials insights
Gather financial insights about LyGenesis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Debt
$4M
2020
Debt
$11M
2023
Series A
$19M
LyGenesis Tech Stack
A closer look at the technologies used by LyGenesis
Most Recent Scoops
Funding
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Funding
Funding
Funding
LyGenesis News & Media
Data and Safety Monitoring Board Approves LyGenesis's Phase 2a Clinical Trial to Continue and Dose Escalate in Novel Trial of Organ Regeneration
The next four patients will receive a higher dose of LyGenesis's cell therapy to grow functioning liver tissue in patients with end stage liver disease PITTSBURGH, March 4, 2025 /PRNewswire/ -- LyGenesis, Inc., a clinical-stage biotechnology company developing cell therapies for organ...LyGenesis Raises $19M in Series A-2 Funding
LyGenesis, a Pittsburgh, PA-based clinical-stage biotechnology company, raised $19M in Series A-2 funding. The round was led by Prime Movers Lab, with participation form Juvenescence. Justin Briggs, Biologist and Partner at Prime Movers Lab, who will be joining LyGenesis’s Board of Directors. The company intends to use the funds to complete its Phase 2a clinical […] The post LyGenesis Raises $19M in Series A-2 Funding appeared first on FinSMEs.LyGenesis and Imagine Pharma Announce Joint Research Collaboration to Develop Novel Cell Therapies for Patients with Type 1 Diabetes
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes PITTSBURGH, April 11, 2023 /PRNewswire/ -- LyGenesis, Inc., a clinical-stage biotechnology company developing allogenic cell therapies for large unmet needs, and Imagine Pharma,...iTolerance and LyGenesis Announce a Joint Research Collaboration to Regrow Functioning, Ectopic Livers Without the Need for Immune Suppression
MIAMI and PITTSBURGH, June 30, 2022 /PRNewswire/ -- iTolerance, Inc., an early-stage regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the need for life-long immunosuppression and LyGenesis, Inc., a clinical-stage biotechnology company...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LyGenesis
Sign Up For FreeTo access detailed company insights
LyGenesis, Inc. is a clinical-stage cell therapy company that focuses on addressing life-threatening diseases such as Type 1 diabetes and end-stage liver and renal disease. Their innovative approach utilizes patients' lymph nodes as bioreactors to grow functioning ectopic organs, significantly improving the economics and logistics of organ transpla... Read More
